Equillium, Inc. (EQ)
1.27
-0.15
(-10.56%)
USD |
NASDAQ |
Oct 22, 16:00
1.26
-0.01
(-0.79%)
After-Hours: 20:00
Equillium Price : 1.27 for Oct. 22, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | 1.40 | 1.420 | 1.23 | 1.27 | 315473.0 |
| Oct 21, 2026 | 1.40 | 1.51 | 1.385 | 1.42 | 442539.0 |
| Oct 20, 2026 | 1.25 | 1.43 | 1.24 | 1.38 | 774544.0 |
| Oct 19, 2026 | 1.22 | 1.291 | 1.16 | 1.24 | 3.192M |
| Oct 16, 2026 | 1.32 | 1.35 | 1.185 | 1.19 | 466785.0 |
| Oct 15, 2026 | 1.30 | 1.38 | 1.28 | 1.32 | 510932.0 |
| Oct 14, 2026 | 1.32 | 1.38 | 1.30 | 1.30 | 263775.0 |
| Oct 13, 2026 | 1.50 | 1.50 | 1.32 | 1.32 | 397772.0 |
| Oct 12, 2026 | 1.42 | 1.51 | 1.39 | 1.50 | 383748.0 |
| Oct 09, 2026 | 1.45 | 1.46 | 1.38 | 1.41 | 521997.0 |
| Oct 08, 2026 | 1.41 | 1.46 | 1.34 | 1.44 | 645030.0 |
| Oct 07, 2026 | 1.41 | 1.425 | 1.35 | 1.39 | 343324.0 |
| Oct 06, 2026 | 1.39 | 1.47 | 1.37 | 1.42 | 393616.0 |
| Oct 05, 2026 | 1.37 | 1.455 | 1.30 | 1.45 | 795620.0 |
| Oct 02, 2026 | 1.55 | 1.60 | 1.375 | 1.41 | 934793.0 |
| Oct 01, 2026 | 1.67 | 1.67 | 1.525 | 1.54 | 529400.0 |
| Sep 30, 2026 | 1.63 | 1.655 | 1.58 | 1.625 | 3.104M |
| Sep 29, 2026 | 1.68 | 1.72 | 1.61 | 1.62 | 316291.0 |
| Sep 28, 2026 | 1.65 | 1.715 | 1.63 | 1.68 | 241729.0 |
| Sep 25, 2026 | 1.70 | 1.71 | 1.66 | 1.67 | 137755.0 |
| Sep 24, 2026 | 1.72 | 1.74 | 1.65 | 1.72 | 280737.0 |
| Sep 23, 2026 | 1.91 | 1.91 | 1.69 | 1.75 | 504604.0 |
| Sep 22, 2026 | 1.90 | 1.95 | 1.81 | 1.93 | 3.072M |
| Sep 21, 2026 | 1.98 | 1.98 | 1.85 | 1.895 | 266468.0 |
| Sep 18, 2026 | 1.89 | 1.995 | 1.860 | 1.92 | 853468.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.31 |
| Alnylam Pharmaceuticals, Inc. | 227.28 |
| Anika Therapeutics, Inc. | 21.09 |
| Savara, Inc. | 4.54 |
| Vericel Corp. | 42.97 |
Price Related Metrics
| Price to Book Value | 1.438 |
| Earnings Yield | -15.99% |
| Market Cap | 80.53M |